Actively Recruiting
Registry of Chronic Subdural Hematoma
Led by Erasmus Medical Center · Updated on 2025-01-07
1500
Participants Needed
2
Research Sites
326 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to better understand how chronic subdural hematoma (CSDH) progresses and how patients are treated and cared for. The study focuses on three main questions: 1. What are the characteristics of patients with CSDH when they are diagnosed? 2. What treatments do patients with CSDH receive? 3. What are the outcomes for patients with CSDH, including their functional ability, cognitive health, and neurological status? Participants will receive their usual standard treatment. As part of the study, they will complete a brief telephone interview three months after their treatment.
CONDITIONS
Official Title
Registry of Chronic Subdural Hematoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with CSDH
- 18 years or older
You will not qualify if you...
- Patients who do not consent to participate in the registry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Amsterdam UMC
Amsterdam, Netherlands
Actively Recruiting
2
Erasmus MC
Rotterdam, Netherlands
Actively Recruiting
Research Team
R
Rahman Fakhry
CONTACT
D
Dana C. Holl
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here